EVOTEC INTERNATIONAL GMBH

Patent Applications and Registrations

Patent applications and USPTO patent grants for EVOTEC INTERNATIONAL GMBH.The latest application filed is for "modulators of the integrated stress response pathway".

Company Profile

2.11.15

EVOTEC INTERNATIONAL GMBH - Hamburg DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks

Patent Activity

Patent	Date
Modulators Of The Integrated Stress Response Pathway App 20220227747 - ATTON; Holly ; et al.	2022-07-21
Modulators Of The Integrated Stress Response Pathway App 20220213078 - BROWN; Christopher John ; et al.	2022-07-07
Combination Therapy For Treating Hepatitis B Virus Infection App 20210260165 - ALAM; Antoine ; et al.	2021-08-26
Pyrazolopyrimidine Compounds As Adenosine Receptor Antagonists App 20210251995 - BELL; Andrew Simon ; et al.	2021-08-19
Treatment of sleep disorders Grant 10,370,378 - Kemp , et al.	2019-08-06
Sulfoximine substituted quinazolines for pharmaceutical compositions Grant 10,167,296 - Blum J	2019-01-01
Sulfoximine substituted quinazolines for pharmaceutical compositions Grant 10,093,660 - Kley , et al. October 9, 2	2018-10-09
Inhibitors Of Bacterial Glycosyl Transferases App 20180162862 - Gampe; Christian M. ; et al.	2018-06-14
Sulfoximine Substituted Quinazolines For Pharmaceutical Compositions App 20170260195 - BLUM; Andreas	2017-09-14
Sulfoximine substituted quinazolines for pharmaceutical compositions Grant 9,708,274 - Blum , et al. July 18, 2	2017-07-18
Sulfoximine Substituted Quinazolines For Pharmaceutical Compositions App 20170174668 - Kley; Joerg ; et al.	2017-06-22
Novel Neurturin Conjugates For Pharmaceutical Use App 20160060317 - Austen; Matthias ; et al.	2016-03-03
Screening methods for compounds useful for treating pancreatic dysfunction Grant 9,049,849 - Dohrmann , et al. June 9, 2	2015-06-09
Neurturin conjugates for pharmaceutical use Grant 9,029,323 - Austen , et al. May 12, 2	2015-05-12
Method For Preventing And Treating Diabetes Using Neurturin App 20140274897 - Austen; Matthias ; et al.	2014-09-18
Treatment Of Sleep Disorders App 20140228562 - Kemp; John Alan ; et al.	2014-08-14
Use Of Pleitrophin For Preventing And Treating Pancreatic Diseases And/or Obesity And/or Metabolic Syndrome App 20140213510 - ONICHTCHOUK; Daria ; et al.	2014-07-31
Method for promoting regeneration of pancreatic beta-cells by administering neurturin Grant 8,772,233 - Austen , et al. July 8, 2	2014-07-08
Formulation For Increasing Bioavailability Of Neurturin App 20140162948 - Harder; Friedrich ; et al.	2014-06-12
Use of pleitrophin for preventing and treating pancreatic diseases and/or obesity and/or metabolic syndrome Grant 8,501,473 - Onichtchouk , et al. August 6, 2	2013-08-06

Company Registrations

NCAGE Code	CL152	EVOTEC INTERNATIONAL GMBH
CAGE Code	CL152	EVOTEC INTERNATIONAL GMBH
S.A.M. Registration	CL152 [313165693]	EVOTEC INTERNATIONAL GMBH

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.